Topics

Companies Related to "German drug assessment body convinced Bayer cancer drug" [Most Relevant Company Matches] RSS

08:20 EST 21st February 2020 | BioPortfolio

Here are the most relevant search results for "German drug assessment body convinced Bayer cancer drug" found in our extensive corporate database of over 50,000 company records.

Showing "German drug assessment body convinced Bayer cancer drug" Companies 1–25 of 6,800+

Relevant

Presage Biosciences

Presage Biosciences is an oncology company pioneering the incorporation of human efficacy data much earlier in the drug development and clinical trial processes with its patented CIVO arrayed microinjection platform. The CIVO platform allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a ...


Bio-Path Holdings, Inc.

Bio-Path is developing a patented, liposomal drug delivery system and products developed at The University of Texas M. D. Anderson Cancer Center, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development.

Bayer USA Foundation

The Bayer USA Foundation is an endowed 501(c)(3) entity and is the primary source of Bayer Corporation’s philanthropy in the United States. With a programmatic focus on the environment and sustainability; education and workforce development; arts and culture; and health and human services, the foundation creates and supports organizations that improve...


mdc medical device certification GmbH

In 1994 mdc was notified by the German Ministry of Health (Bundesministerium für Gesundheit) to the European Commission for conformity assessment procedures under the European Medical Device Directive 93/42/EEC as one of the first German entities. The Commission assigned us the identification number 0483 and listed mdc as Notified Body in the official journal.mdc is not a newcomer in the medica...

Nagourney Cancer Institute

The Nagourney Cancer Institute is a clinical research center that has pioneered the study of human tumor tissue for individualized cancer patient drug selection and has facilitated cancer drug discovery.

BAYER AG

Drug Discovery

IOmet Pharma

IOmet Pharma Ltd is a privately-held drug discovery company based in Edinburgh, UK. Founded in 2008, IOmet is focused on the development of innovative medicines for the treatment of cancer, with particular emphasis on the fields of cancer immunotherapy and cancer metabolism. IOmet has a team with a proven track record of success in bringing small molecules...

ORYX GmbH & Co. KG

ORYX is a privately held Munich-based biotech company. ORYX is developing three highly innovative drug candidates for the treatment of cancer, originating from leading research institutions like the German Cancer Research Center (DKFZ) and the University of Heidelberg. The ORYX clinical development portfolio consists of an oncolytic virus and two therapeut...

Data Security Officer, Bayer AG:

From world-renowned drug products to the high-tech platform, from innovative diagnostics technology to veterinary medicines – Bayer HealthCare is a health care company of international repute.It covers the fields of animal health, genetically produced medicines, over-the-counter products, diagnostic products and prescription drugs. Bayer HealthCare builds upon a foundation that is steeped in tra...

Bayer MaterialScience AG

Bayer MaterialScience AG is an independent, globally operating company within the Bayer Group. The name Bayer MaterialScience stands for the materials that the company develops and produces. It also stands for the know-how and expertise of its employees all over the world, who register on average one new patent every working day. This spirit is embodied by the company’s mission statement "Vision...

Bayer Diabetes Care

Bayer Diabetes Care is a worldwide leader in diabetes care, supporting customers in 100 countries and, for more than 40 years, has led the way in diabetes care product innovation. Today, Bayer Diabetes Care offers an unparalleled choice in diabetes management systems and comprehensive support including education, tools and resources designed to simplify life with diabetes. Bayer Diabetes Care is a...

Telik, Inc.

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer. The company's most advanced drug candidates in clinical development are Telintra, a modified glutathione analog for the treatment of MDS and Severe Chronic Neutropenia (SCN), and Telcyta®, a cancer activated prodrug for the treatment of advanced n...

Nastech Pharmaceutical

Nastech Pharmaceutical Company Inc. is a Formulation Science specialty company that utilizes biophysics, physical chemistry and pharmacology to bridge the gap between drug discovery and drug optimization.Nastech’s proprietary Systemic Transnasal Absorption Technology (STA-T™), Paracellular Transport System (PTS™), and Junction Activator Technology (JAT™) provide rapid assessment of the mer...

Shimoda Biotech (pty) Ltd

Shimoda Biotech (Proprietary) Limited ("Shimoda") is a leading South African biopharmaceutical discovery company that focuses on the development of innovative, proprietary drug delivery systems and novel therapeutic compounds. Shimoda's primary focus is on the development of proprietary drug delivery systems that enable the efficient delivery of drug molecules, proteins and genes to selected sites...

Bayer CropScience LP

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience AG, a subsidiary of Bayer AG with annual sales of about EUR 6.4 billion (2008), is one of the world's leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and plant biotechnology. The company offers an outs...

Curis, Inc.

Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer. Curis is building upon its previous experiences in targeting signaling pathways, including in the Hedgehog pathway, in its effort to develop proprietary targeted can...

INEX

INEX is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer. INEX does not yet have products on the market. INEX’s lead product is Marqibo™ (sphingosomal vincristine), a proprietary drug comprised of the widely used, off-patent, anticancer drug vincristine and the Company's drug delivery technology.

GenSpera, Inc.

GenSpera, Inc. is a development stage oncology company focused on therapeutics that deliver a potent, unique and patented drug directly to tumors. GenSpera’s technology platform combines a potent cytotoxin (12ADT) with a pro-drug delivery system that activates the drug only within the tumor. Unlike standard cancer drugs, plant-derived 12ADT kills cell...

AcuityBio Inc. and Cook Biotech Inc.

AcuityBio has developed a platform technology for localized, sustained, safe drug-delivery to be used in the prevention of post-surgical lung cancer recurrence. ABC103 combines approved/ cleared surgical staple-line buttress, drug eluting polymers and a chemotherapeutic drug, paclitaxel). ABC103 has been granted US FDA orphan drug designation for this indi...

Gentium S.p.A.

Gentium S.p.A., located in Como, Italy, is a biopharmaceutical company focused on the development and manufacture of drugs to treat and prevent a variety of diseases and conditions, including vascular diseases related to cancer and cancer treatments. Defibrotide, the Company's lead product candidate, is an investigational drug that has been granted Orphan ...

Takeda San Diego

Takeda San Diego (TSD) is Takeda's global center for excellence in structure-based drug discovery. TSD integrates cutting-edge protein crystallography and drug discovery technologies to efficiently generate Investigational New Drug (IND) candidates for the treatment of metabolic diseases and cancer. Multiple drug candidates discovered at TSD are currently in clinical trials including SYR322, a pot...

AuraZyme™ Pharmaceuticals

AuraZyme™ Pharmaceuticals is a development stage company founded to develop and commercialize therapeutic drug formulations that increase efficacy of drug therapy, lower drug dosage requirements, reduce side effects, and improve outcomes. AuraZyme is building a portfolio of targeted AZ-CINN™ drug conjugates and AZ-Enzymes™ to address multiple medical needs, including cancer, infection, and ...

Advinus Therapeutics

Advinus Therapeutics is a research-based Pharmaceutical Company founded by leading global pharmaceutical executives and promoted by the TATA Group. The company is the first of its kind in India to offer end-to-end development services to the global Pharma, Agro and Biotech industries and at the same time creating long-term value through internal and collab...

Seattle Genetics, Inc.

Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The company's lead product candidate, brentuximab vedotin (SGN-35), is in a pivotal trial under a Special Protocol Assessment with the U.S. Food and Drug Admin...

Axiom Biotechnologies Incorporated

Axiom Biotechnologies are an emerging biopharmaceutical company focused on the rapid discovery and development of more effective and safer drugs through the use of our proprietary human cell-based Physiogenomics technology. The technology integrates their Human Cell Bank, containing over 100 human cell lines representing all the major tissues of the human body, and their proprietary cell assay tec...


More From BioPortfolio on "German drug assessment body convinced Bayer cancer drug"

Quick Search

Corporate Database Quicklinks